ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2024

IMpower210: A phase III study of second-line atezolizumab

Yi-Long Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.